Chairmen
Stefano Del Prato
a Department of Endocrinology and Metabolism, University of Pisa, Italy
Ele Ferrannini
Internal Medicine, University of Pisa, Italy

SCIENTIFIC BOARD
L. Benzi, G. Di Cianni, R. Miccoli, G. Penno
Department of Endocrinology and Metabolism,
Section of Diabetes, University of Pisa, Italy
Phone: +39 050 995103 - Fax: +39 050 541521
E-mail: metabpi@immr.med.unipi.it www.diab.it
SCIENTIFIC SECRETARIAT
One Way Publishing
Via della Moscova, 16 - 20121 Milan - Italy
Phone: +39 02 29062649 - Fax: +39 02 45490281
Contact person: Karin Berger
E-mail: k.berger@onewaynet.it
ORGANISING SECRETARIAT
Newtours S.p.A.
Via A. Righi, 8 - 50019 Sesto Fiorentino - Florence - Italy
Phone: +39 055 3361315
Contact person: Patrizia Uboldi
E-mail: uboldi@newtours.it
With the endorsement of
Sociètà Italiana di Diabetologia - SID
Associazione Medici Diabetologi - AMD
CME credits and UEMS credits for Italian and European participants have been requested

PROGRAMME

Friday, 10 November

9.00 Opening remarks
Session 1: Diabetes: the emerging problem - Chairperson: A. Tiengo (Padua, Italy)
09.30 - 10.00 E. Bonora (Verona, Italy) - Diabetes epidemic: the Italian study case
10.00 - 10.30 K.G.M.M. Alberti (London, U.K.) - Prediabetes - Definition and reality
10.30 - 11.00 J. Tuomilehto (Helsinki, Finland) - People at risk of diabetes: how to find them?
11.00 Break
Session 2: From pre-diabetes to diabetes - Chairperson: R. Giorgino (Bari, Italy)
11.30 - 12.00 R.C. Bonadonna (Verona, Italy) - IGT - Diabetes or CVD risk?
12.00 - 12.30 S. Del Prato (Pisa, Italy) - Genetic and pathophysiology of type 2 diabetes:
the GENFIEV study
12.30 - 13.00 E. Ferrannini (Pisa, Italy) - From IGT to diabetes: how does it happen?
13.00 Lunch
Session 3: Pre-diabetes: which culprit? - Chairperson: C.M. Rotella (Florence, Italy)
14.30 - 15.00 M. Stumvoll (Leipzig, Germany) - From obesity to diabetes
15.00 - 15.30 G.I. Shulman (New Haven, U.S.A) - Is there a starting point?
15.30 - 16.00 J.B. Meigs (Boston, U.S.A.) - Diabetes: an inflammatory disease?
Session 4: Addressing pathophysiologic mechanism - Chairperson: R. Lauro (Rome, Italy)
16.30 - 17.00 R. Holman (Oxford, U.K.) - Navigation toward effective prevention: NAVIGATOR study
17.00 - 17.30 H.C. Gerstein (Hamilton, Canada) - Prevention of diabetes: a DREAM?
17.30 - 18.00 E. Standl (Munich, Germany) - Metformin for prevention of type 2 diabetes and CV risk

Saturday, 11 November

Session 5: Searching for the genes - Chairperson: V. Trischitta (Rome, Italy)
09.00 - 09.30 L. Groop (Malmö, Sweden) - Can we hope for a genetic screening?
09.30 - 10.00 F. Giorgino (Bari, Italy) - Differentiating diabetic phenotypes: the monogenic forms
10.00 - 10.30 P. Froguel (London, U.K.) - How do genes mix up to cause type 2 diabetes?
10.30 Break
Session 6: Special risk conditions - Chairperson: M. Muggeo (Verona, Italy)
11.00 - 11.30 S. Caprio (New Haven, U.S.A.) - Obesity in children
11.30 - 12.00 A. Avogaro (Padua, Italy) - Myocardial infarction: a dramatic time for development
of diabetes
12.00 - 12.30 G. Grassi (Monza, Italy) - Using cardioprotective agents to prevent diabetes
12.30 Lunch
Session 7: Modifying risk factors and public outcomes - Chairperson: G. Crepaldi (Padua, Italy)
14.00 - 14.30 G. Riccardi (Naples, Italy) - Lifestyle modification for preventing diabetes
14.30 - 15.00 J.L. Chiasson (Montreal, Canada) - Post-prandial hyperglycaemia: the STOP-NIDDM lesson
15.00 - 15.30 D.M. Eddy (Aspen, U.S.A.) - Clinical outcomes and cost effectiveness of strategies
for managing people at risk for diabetes
15.30 - 16.00 M. Hirst (London, U.K.) - How to increase diabetes awareness: the role of the media
16.00 Closing remarks